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The Brucella abortus two-component regulatory system BvrR/BvrS controls the expression of outer membrane
proteins (Omp) Omp3a (Omp25) and Omp3b (Omp22). Disruption of bvrS or bvrR generates avirulent mutants
with altered cell permeability, higher sensitivity to microbicidal peptides, and complement. Consequently, the role
of Omp3a and Omp3b in virulence was examined. Similar to bvrS or bvrR mutants, omp3a and omp3b mutants
displayed increased attachment to cells, indicating surface alterations. However, they showed unaltered permeabil-
ity; normal expression of Omp10, Omp16, Omp19, Omp2b, and Omp1; native hapten polysaccharide; and lipo-
polysaccharide and were resistant to complement and polymyxin B at ranges similar to those of the wild-type (WT)
counterpart. Likewise, omp3a and omp3bmutants were able to replicate in murine macrophages and in HeLa cells,
were resistant to the killing action of human neutrophils, and persisted in mice, like the WT strain. Murine
macrophages infected with the omp3a mutant generated slightly higher levels of tumor necrosis factor alpha than
the WT, whereas the bvrSmutant induced lower levels of this cytokine. Since the absence of Omp3a or Omp3b does
not result in attenuation, it can be concluded that BvrR/BvrS influences additional Brucella properties involved in
virulence. Our results are discussed in the light of previous works suggesting that disruption of omp3a generates
attenuated Brucella strains, and we speculate on the role of group 3 Omps.
Members of the genus Brucella are intracellular bacterial
pathogens of mammals (33). The ability of Brucella to invade and
replicate in cells has been linked to its outer membrane (OM)
properties as well as to structures built within the cell envelope
(31, 32, 34). Among these, the lipopolysaccharide (LPS), the
-1,2-cyclic glucans, the type IV secretion system VirB, and
the flagellum-like system are the most studied (2, 6, 17, 27). The
notion that the Brucella OM plays a key role in virulence has been
reinforced by the identification of the two-component regulatory
system BvrR/BvrS, which controls the expression of at least two
OM proteins (Omps), Omp3a and Omp3b, as well as the struc-
ture of the LPS (22, 28). Although they do not demonstrate
obvious growth defects in vitro, the bvrS and bvrR mutants are
avirulent in mice, displaying reduced invasiveness and replication
in professional and nonprofessional phagocytes (7, 42).
Omp3a and Omp3b, also known as Omp25 and Omp22,
respectively, belong to group 3 of the Brucella Omps (22, 37,
44, 45), a highly conserved family of up to seven members that
includes some of the most abundant and immunogenic Brucella
proteins (10). The function of group 3 Omps is not completely
understood. The strong association of some of the members
with LPS suggests that they play an important structural role in
the OM (19, 37). In Brucella abortus, the gene encoding
Omp31A is absent and the gene encoding Omp25b is trun-
cated (23, 46), suggesting that neither of these Omps plays a
significant role in Brucella virulence, although they still may
participate in host preferences. Omp31A is a hemin-binding
protein, and its expression is induced by iron limitation (11).
The virulence of B. melitensis Rev1 Omp31A mutants, how-
ever, does not differ from the parental Rev1 counterpart (8).
These apparent inconsistencies may be accounted for in part
by the redundancy of iron uptake systems in Brucella (11).
There are several reports indicating that B. abortus Omp3a is
involved in virulence (14–16) and that it acts as a negative
regulator of tumor necrosis factor alpha (TNF-) production
in human macrophages (24). Since the levels of Omp3a and
Omp3b expression are severely diminished in B. abortus bvrS
and bvrR mutants and these mutants are avirulent (22, 42), we
decided to construct omp3a and omp3b knockout strains and to
explore their biological characteristics. Although omp3a and
omp3b mutants displayed some surface properties that distin-
guished them from the parental strain, we found that they did
not reproduce the defects of the bvrS or bvrR mutants and
remained virulent in the systems tested.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The relevant characteris-
tics of the bacterial strains and plasmids used in this study are listed in Table 1.
Escherichia coli and Brucella strains were grown on tryptic soy broth, tryptic soy
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agar, or blood agar base (BAB). When needed, nalidixic acid (Nal; 25 g/ml),
kanamycin (Km; 50 g/ml), or ampicillin (Amp; 100 g/ml) was added to the
cultures. Growth ability was tested in tryptic soy broth, brain heart infusion
broth, and Gerhardt’s modified minimal medium using an automatic microbiol-
ogy analyzer (Bioscreen C; Labsystems, Vantaa, Finland).
DNA and RNA manipulations. Plasmid and chromosomal DNA were ex-
tracted with QIAprep spin miniprep (QIAGEN GmbH, Hilden, Germany) and
Ultraclean microbial DNA isolation (MO BIO Laboratories, Inc.) kits, respec-
tively. Primers were synthesized by Sigma-Genosys (Haverhill, United King-
dom). For RNA manipulation, bacterial cultures adjusted to 109 CFU/ml were
disrupted with 0.5% Zwittergent 3-16 at 37°C for 1 h. Then, total RNA was
extracted using an RNeasy minikit (QIAGEN) according to the manufacturer’s
instructions. RNA (0.2 g) was used as a template for the synthesis of cDNA
with SuperScript III reverse transcriptase (RT) (Invitrogen) using the random
hexamers from the same kit.
Construction and characterization of omp3a and omp3b mutants. The B.
abortus 2308 omp3a::Km mutant was constructed by homologous recombination
between the chromosomal omp3a gene and plasmid pSK3aKm carrying an
omp3a::Km construct from pAC2553 (Table 1). This omp3a::Km construct was
obtained after cleavage of the B. abortus 2308 omp3a gene with StyI and the insertion
of a kanamycin resistance cassette. In order to facilitate plasmid mobilization by
conjugation, omp3a::Km was subcloned from pAC2553 into the mobilizable plasmid
pSK-oriT (43) as an XbaI-SacI 2.1-kb fragment, generating plasmid pSK3aKm. This
new construct was confirmed by PCR with primers Omp25U1 (5-TGCGCTGCT
GCCGTTCTCTG-3) and Omp25L1 (5-GGATCCGGCCAGATCATAGTTCTT
GT-3), which amplify a specific 547-bp fragment of the omp3a gene, and by double
digestion with EcoRI and HindIII. Plasmid pSK3aKm was introduced into B. abortus
2308 by conjugation with E. coli SM10 ( pir) (39). The first recombination event
(vector integration in the Brucella chromosome) was selected by Nal and Km resis-
tance, and the second recombination event (excision of the mutator plasmid) was
selected by Amp sensitivity. To confirm the mutation, different colonies were
screened by PCR with primers Omp25U1 and Omp25L1. EcoRV-digested genomic
DNA from selected clones was analyzed by Southern blotting using pSK-oriT,
pSK3aKm, and pTA3a (Table 1) as probes and by RT-PCR as previously described
(28) with primers Omp25U1 and Omp25L1. Failure to express Omp3a was con-
firmed by Western blotting using OM fragments (18) or Sarkosyl-resistant fractions
with anti-Omp3a monoclonal antibodies (MAbs) A70/06B05/A07 and A76/02C12/
C11 (9, 42). The B. abortus omp3b::Km mutant was constructed as follows. First, B.
abortus 2308 omp3b was amplified by PCR with specific primers BAF-1 (5-CCCG
GCTGTTACATATGCTG-3) and BAF-2 (5-CGCGCTGATATCGACATGAC-
3) and cloned into vector pCR2.1 (Invitrogen). The resulting plasmid pTA3b was
used as a template for inverse PCR mutagenesis to delete omp3b. This plasmid was
first denatured with 1 M NaOH and 1 mM EDTA for 15 min at 37°C, neutralized
with 3 M sodium acetate (pH 4.8), purified with ethanol, and finally resuspended in
water (13). The sample was then inverse amplified with primers IM3B-1 (5-ACG
CGTCGACGCCGGCCTGAACTACAA-3) and IM3B-2 (5-ACGCGTCGACG
CGGCGACAGGGTCGTTAT-3) carrying a restriction site for SalI (underlined in
the primer sequences). After 5 min at 95°C, amplification was carried out for 30
cycles of 1 min at 95°C, 45 s at 63°C, and 45 s at 68°C, and a final extension at 68°C
for 10 min. The 4.5-kb amplified fragment was purified, digested with SalI, and
religated to generate plasmid pTA3b. To facilitate the counterselection of the
mutant, a Km resistance cassette from plasmid pUC4K (Amersham Pharmacia
Biotech, NJ) was cloned in the SalI site. The mutated omp3b gene was subcloned
into pSK-oriT as an EcoRI 1.9-kb fragment generating plasmid pSK3bKm. This
construct was verified by PCR with primers BAF-1 and BAF-2 and by digestion with
EcoRI and SalI. Plasmid pSK3bKm was introduced into B. abortus 2308 by conju-
gation with E. coli SM10 ( pir) and Nalr Kmr Amps transconjugants were selected.
The resulting colonies were screened by PCR with primers BAF-1 and BAF-2 and
primers C3BK-2 (5-CCGCGCGGACACCAAGCCTA-3) and C3BK-1 (5-CGG
CGGCGTGACGGATGAAG-3), which amplify a 1.9-kb fragment of the omp3b
gene. Mutation was confirmed by Southern blotting using plasmids pSK-oriT,
pSK3bKm, and pTA3b as probes and EcoRI-digested genomic DNA, as well as by
RT-PCR with specific primers 3bZ-1 (5-GCGCGCAGGTTGGTGGTT-3) and
3bZ-2 (5-GGATCCGCCGGCCTTGATCGAATG-3), which amplify a specific
473-bp fragment of the omp3b gene. The absence of Omp3b was corroborated by
two-dimensional (2D) gel analysis of the OM fragments of the omp3b mutant and
the wild-type (WT) strain as previously described (22).
To determine the stability of the omp3a and omp3b mutants in vitro, bacteria
were grown on BAB for 24 h and serial dilutions were plated on BAB, BAB-Nal,
BAB-Km, and BAB-Amp. In vivo stability was determined in the mouse model.
TABLE 1. Bacterial strains and plasmid constructs used in this study
Strain or plasmid Relevant characteristics Reference orsource
Strains
B. abortus
2308 Nalr Virulent WT strain, biotype 1, LPS-S, spontaneous Nalr mutant 39
bvrS mutant strain 2.13 2308 Nalr bvrS::Tn5 42
bvrR mutant strain 65.21 2308 Nalr bvrR::Tn5 42
bvrR strain 65.21p 65.21 carrying plasmid pBBR2.13 42
omp3a mutant 2308 Nalr omp3a::Km This work
omp3b mutant 2308 Nalr omp3b::Km This work
E. coli
SM10 ( pir) thi-1 thr leu tonA lacY supE recA::RP4-2-Tet::Mu Kmr;  pir 40
XL1-Blue Tetr supE44 hsdR17 recA1 endA1 gyrA96 thi relA1 lac F proAB lacIq
lacZ	M15 Tn10 (Tetr)

38
TOP 10 F F lacIq Tn10 (Tetr)
 mcrA 	(mrr-hsdRMS-mcrBC) 80lacZ	M15 	lacX74
recA1 araD139 	(ara-leu) 7697 galU galK rpsL (Strr) endA1 nupG
Invitrogen
Plasmids
pCR2.1 High-copy-number cloning vector; Ampr Kmr Invitrogen
pUC4K Plasmid containing kanamycin resistance cassette Stratagene
pSK-oriT pBluescript II SK(-) oriT RK2 Ampr 43
pBBR1MCS-4 Intermediate-copy-number cloning vector; Ampr 25
pAC2553 pUC19 containing 	omp3a::Km A. Cloeckaert
pSK3aKm pSK-oriT containing 	omp3a::Km (1.8 kb) This work
pTA3a pCR2.1 containing an internal fragment of B. abortus 2308 omp3a amplified by
PCR (0.55 kb)
This work
pTA3b pCR2.1 containing complete B. abortus omp3b gene amplified by PCR (1.1 kb) This work
pTA3b pCR2.1 containing deleted omp3b gene (0.6 kb) This work
pSK3b-Km pSK-oriT containing 	omp3b::Km (1.9 kb) This work
pBBR3b pBBR1MCS-4 containing B. abortus omp3b gene (1.1 kb) This work
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Groups of five BALB/c mice (see below) were inoculated intraperitoneally with
0.1 ml of a suspension containing 105 CFU of each bacterial strain, and 2 weeks
later they were sacrificed and the spleens were removed. Each spleen was ho-
mogenized, and decimal dilutions were plated in triplicate samples on BAB,
BAB-Nal, BAB-Km, and BAB-Amp. Mutants were considered stable in vivo and
in vitro when viable counts were the same in all media. LPS stability (smooth LPS
versus rough-type LPS) and the presence of native hapten (NH) polysaccharide
was also verified by crystal violet staining, immunodiffusion, immunofluores-
cence, and Western blotting (1, 28). Regular typing and sensitivity to colorants
and phages were determined as described elsewhere (1).
Immunological methods. Cell envelope components were analyzed and immu-
nodetected as described previously (22). Direct, indirect, and double immunofluo-
rescence assays for the determination of extracellular and intracellular bacteria were
performed as described elsewhere (21, 35). The levels of TNF- in a supernatant
medium of B. abortus-infected murine RAW 264.7 macrophages were measured by
enzyme-linked immunosorbent assay (BD Biosciences, San Diego, CA) at different
time intervals according to the manufacturer’s instructions.
Sensitivity to polymyxin B, antibiotics, and nonimmune serum. Sensitivity to
polymyxin B was tested as described elsewhere (42). The sensitivity to several
hydrophilic and hydrophobic antibiotics was tested as described previously (29).
The sensitivity to the bactericidal action of human and bovine serum was esti-
mated by the method described by Skurnik et al. (41).
Internalization, survival, and replication assays in cells and mice. Ex vivo
infection assays were performed with HeLa cells (ATCC CCL-2), murine RAW
264.7 macrophages (ATCC TIB-71), and human polymorphonuclear neutrophils
(PMN). Cell cultures and gentamicin survival assays were performed as described
previously (6, 7, 21, 35, 47). For double immunofluorescence analysis of Brucella-
infected HeLa or RAW 264.7 cells, procedures described previously were followed
(6, 35). Counts of intracellular and extracellular bacteria were performed for at least
50 infected cells and were expressed as the mean and standard deviation of the
percentage of intracellular bacteria and the number of bacteria per infected cell. The
percentage of cells with associated bacteria (intra- and extracellular) was expressed
as the mean and standard deviation of numbers of cells with bound bacteria in five
different 400 magnification fields. Statistical analysis was performed using Stu-
dent’s t test. PMN were purified from defibrinated blood extracted from human
donors with no history of brucellosis. One part of blood diluted with 1 part minimal
essential medium containing 5% inactivated fetal calf serum, with 25 mM HEPES
and 2 mM glutamine (Sigma-Aldrich, Co). Eight milliliters of diluted blood was
layered on the top of a biphasic gradient of Ficoll-Histopaque (3 ml with a density
of 1.077 0.001 on the top of 3 ml with a density of 1.119 0.001; Sigma) on a conic
tube and centrifuged at 4°C for 30 min at 700 g. Granulocytes were extracted from
the interphase between the two Ficoll layers, washed in supplemented medium
without antibiotics, and counted. Infections were performed with 2-ml plastic tubes
by mixing 5  105 PMN with 5  106 Brucella cells in a total volume of 250 l of
medium without antibiotics. The tubes were incubated at 37°C for 1 h with mild
agitation. Finally, the mixture was centrifuged, the supernatants were removed, and
the cells were lysed with 100 l 0.1% Triton X-100. Dilutions of cell lysates were
plated on tryptic soy agar, and the bacterial CFUs were counted after 3 days of
incubation. The number of internalized Brucella cells in the PMN was recorded by
immunofluorescence, as described previously (35).
Female BALB/c mice were infected by the intraperitoneal route with 105 CFU
of B. abortus omp3a, omp3b, or WT strains as described previously (42). For the
bvrS or bvrR mutant, doses of 108 CFU were used. For each strain, 30 mice were
inoculated and the numbers of CFU in spleens were determined at various times
postinfection. Statistical comparisons were performed by the Fisher’s protected
least significant differences test.
RESULTS
B. abortus omp3a and omp3b mutants do not display signif-
icant phenotypic deviations from the WT. Independent disrup-
tion of omp3a and omp3b in B. abortus by the introduction of a
kanamycin cassette was corroborated by RT-PCR and Western
FIG. 1. Construction of B. abortus omp3a and omp3b mutants.
(A) RT-PCR using specific primers for omp3a (top) and omp3b (bottom).
Total RNA was extracted and retrotranscribed, and cDNA was amplified
by PCR with primers Omp25U1/Omp25L1 and 3bZ-1/3bZ-2. Lanes: M,
molecular size markers; WT, B. abortus 2308; omp3a, B. abortus omp3a
mutant; omp3b, B. abortus omp3b mutant; C-, PCR-negative control with
water; C, PCR-positive control with Brucella genomic DNA. (B) De-
tection of Omp3a by Western blotting in cell envelope Sarkosyl-resistant
fractions using anti-Omp3a MAbs. Lanes: WT, B. abortus 2308; bvrR, B.
abortus bvrR::Tn5 mutant; bvrR, reconstituted B. abortus bvrR; omp3a,
B. abortus omp3a deletion mutant; omp3b, B. abortus omp3b deletion
mutant.
FIG. 2. Sensitivity to polymixin B and human complement. (A) Bac-
terial survival in the presence of polymyxin B. The graph shows the
percent survival after 1 h at 37°C with different peptide concentrations.
(B) Bacterial survival after 30- or 90-min incubation with human nonim-
mune serum. Data represent the means standard deviations of percent-
ages of viable bacteria in relation to a bacterial control without polymyxin
B or a bacterial control with heat-inactivated human serum. Samples were
compared using the Mann-Whitney U test. *, P  0.05; **, P  0.005;
***, P  0.0005 (with respect to the WT strain).
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blotting. As expected, no transcription of specific mRNAs for
omp3a or omp3b was detected by RT-PCR (Fig. 1A), and the
absence of Omp3a in the omp3a mutant was demonstrated with
MAbs against Omp3a (Fig. 1B). Antibodies against Omp3b are
not currently available. However, 2D gel analysis of OM frag-
ments of the omp3b mutant, the WT, and the omp3b mutant
transformed with a plasmid encoding Omp3b demonstrated that
protein spots similar to those previously shown to correspond to
Omp3b isoforms (22) were absent in the omp3b mutant prepara-
tions and present in those of the WT and the omp3b mutant
reconstituted strain (data not shown). In regular bacteriological
media, both mutants and the WT showed similar growth patterns.
These mutations did not affect the conventional phenotypic or
metabolic properties described for B. abortus biotype 1 (1) or the
ability of the mutants to grow in complex or defined media. The
sensitivity to antibiotics such as doxycycline, gentamicin, strepto-
mycin, chloramphenicol, penicillin, rifampin, and ciprofloxacin
was similar to that of the WT but different from that of the bvrS
or bvrR mutants, which displayed higher sensitivity (not shown).
The LPS from the omp3a and omp3b mutants was smooth ac-
cording to crystal violet staining, immunofluorescence, and so-
dium dodecyl sulfate-polyacrylamide gel electrophoresis analysis.
Antibodies against Omp10, Omp16, Omp19, Omp2b, Omp1, and
NH polysaccharide revealed quantities of these molecules in the
omp3a and omp3b mutants similar to those in the WT strain (not
shown).
B. abortus omp3a and omp3b mutant resistance to polymixin
B and complement. The avirulent phenotype of the B. abortus
bvrS and bvrR mutants correlates with their higher sensitivity to
bactericidal cationic peptides and complement (28, 42). Although
these features have been linked to structural alterations of the
LPS molecule (28), the role of Omp3a and Omp3b, whose tran-
scription is regulated by the BvrR/BvrS system, has not been
explored. At 10 g/ml of polymyxin B, the omp3a mutant dis-
played levels of polymixin B sensitivity between those of the WT
and the bvrR mutant, whereas the omp3b mutant was as resistant
as the WT (Fig. 2A). At 25 g/ml of polymyxin B, the percent
survival for the omp3a mutant was less than 50% and the percent
survival for the omp3b mutant was similar to that of the WT. As
expected, the percent survival of the bvrR mutant was close to
zero. At 50 g/ml, the omp3a mutant displayed very low levels of
bacterial survival, but the level of survival of the omp3b mutant
was similar to that of the WT strain. At concentrations as high as
100 g/ml, both mutants showed practically no survival. Consis-
tent with previous reports (28), the bvrR mutant was highly sen-
sitive to the action of complement in normal serum after a 30-min
incubation; however, both omp mutants were resistant (Fig. 2B).
The bactericidal effect was more pronounced after 90 min of
incubation in most of the strains. There were no significant dif-
ferences between the omp3b mutant and the WT strain, but in
contrast, the omp3a mutant displayed higher resistance than the
WT strain. Similar results were obtained with bovine nonimmune
serum (data not shown).
B. abortus omp3a and omp3b mutants invade, survive, and
replicate within professional and nonprofessional phagocytes.
B. abortus bvrS and bvrR mutants are poor invaders and fail to
survive and replicate within professional and nonprofessional
phagocytes (42). To test whether their deficiency in Omp3a
FIG. 3. Gentamicin survival assay by double immunofluorescence 30 min postinfection in HeLa cells. (A) Proportion of cells with associated
(intra- and extracellular) bacteria. (B) Proportion of intracellular bacteria with respect to the total of intra- and extracellular bacteria. (C) Absolute
number of intra- and extracellular bacteria per infected cell. Data represent means  standard deviations. Samples were compared using the
Student t test. *, P  0.05; **, P  0.005; ***, P  0.0005 (with respect to the WT strain).
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and Omp3b proteins could explain this phenotype, both omp
mutants were evaluated with HeLa cells by using the gentami-
cin survival assay and double immunofluorescence microscopy
to distinguish intracellular from extracellular bacteria (Fig. 3).
Similar to the bvrS mutant, the omp3a and omp3b mutants
attached to more cells than the WT (Fig. 3A). In contrast to
the bvrS mutant, however, the percentage of intracellular bac-
teria was higher for these mutants than for the WT strain (Fig.
3B). Moreover, the absolute number of bacteria per cell was
higher for all mutants than for the WT. As expected, the
number of intracellular bacteria per cell was significantly
higher for the omp3b and omp3a mutants and significantly
lower for the bvrS mutant than for the WT (Fig. 3C). In order
to analyze the sensitivity of the omp3a and omp3b mutants to
the killing action of cells, HeLa cells, PMN, and RAW 264.7
cells were infected and the replication rates were compared
with those of the WT strain and the avirulent bvrR mutant (Fig.
4). As reported previously (42), the bvrR mutant failed to
replicate in nonprofessional phagocytic HeLa cells and mac-
rophages (not shown). Although the omp3a mutant consis-
tently displayed higher counts at initial times of infection, the
replication levels of both omp mutants were not considerably
different from that of the WT strain at later times (Fig. 4).
Similar results were obtained with naı¨ve bone marrow-derived
murine macrophages (not shown). As expected, the bvrR mu-
tant was readily killed by PMN, while both omp mutants dis-
played a resistance slightly higher than that of the WT strain
(Fig. 4).
B. abortus omp3a and omp3b mutants induce higher levels of
TNF- in murine macrophages than the bvrS mutant. It has
been proposed that Omp3a from B. suis is involved in the
inhibition of TNF- production during infection of human
macrophages (24) but not of murine macrophages (5, 12, 20).
We measured the production of TNF- in murine RAW 264.7
macrophages infected with omp3a or bvrS mutants (Fig. 5).
Consistent with the rates of replication in macrophages, the
levels of TNF- induced by the omp3a mutant were in the
same range as those of the WT. However, the levels of this
cytokine induced by the attenuated bvrS mutant were signifi-
cantly lower.
B. abortus omp3a and omp3b mutants replicate in BALB/c
mice. As described previously (42), the WT strain maintained
high counts in the spleens of BALB/c mice 24 weeks after
infection, while bvrS and bvrR mutants were eliminated within
3 weeks. Similar to the results obtained with cells, the replica-
tion of omp3a and omp3b mutants in mice did not significantly
FIG. 4. Intracellular replication of B. abortus strains in epithelial HeLa cells, RAW 264.7 macrophages (M), and PMN. Data represent
means standard deviations of plate counts. Samples were compared using the Mann-Whitney U test. **, P 0.005; ***, P 0.0005 (with respect
to the WT strain).
FIG. 5. Induction of TNF- in murine RAW 264.7 macrophages
infected with different B. abortus strains. *, P  0.05 (with respect to
the WT strain).
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depart from that of the WT throughout the 24-week period of
the experiment (Fig. 6).
DISCUSSION
We have shown that the absence of either Omp3a or Omp3b
does not lead to phenotypes resembling bvrS or bvrR mutants
but rather to phenotypes similar to that of the WT strain.
Indeed, both omp mutants replicated in macrophages and
epithelial cells to the same extent as the WT, and more im-
portantly, persisted in mice for up to 24 weeks, exhibiting
profiles similar to those of the WT strain. There were, how-
ever, some discrete differences between the omp mutants and
WT Brucella. For instance, both omp mutants bound more
readily to epithelial cells (similar to bvrS and bvrR mutants)
and were slightly more resistant to the killing action of human
PMN. The omp3a mutant was more sensitive to polymixin B
and more resistant to the bactericidal action of complement
after 90 min than the WT strain and induced slightly larger
amounts of TNF- in murine macrophages than the WT (see
below). These results and those obtained for the B. abortus
omp3b mutant in the same set of experiments are slightly
different from those recently reported for two Brucella ovis
omp3a and omp3b mutants (4). The differences in experimen-
tal setups, as well as the fact that B. ovis is a rough bacterium,
might explain these discrepancies. The reason why the B. abor-
tus omp3a mutant is more resistant to the bactericidal action of
complement than the WT remains elusive. It is not known why
B. abortus is more resistant to complement than other bacteria.
Although there is some evidence that indicates that this could
be attributed to its LPS (30), we did not detect any differences
between the mutants’ LPS and the parent strain’s LPS with the
methods used. Nevertheless, the purpose of using these kinds
of experiments is to reveal OM properties that might be al-
tered in the mutants compared to the WT. In this sense, we
could speculate that the absence of Omp3a but not of Omp3b
or both in the mutant strains allows the exposure in the OM of
other molecules that are able to activate complement in higher
levels than the WT.
Besides the nonsignificant variations with respect to the WT
at the LPS level, the B. abortus Omp mutants did not show
important variations in the quantities of other cell envelope
components, such as NH or -cyclic glucans, Omp10, Omp16,
Omp19, Omp2b, and Omp1, or display major differences in
OM permeability or growth rates. However, this does not rule
out the existence of additional changes in other surface mole-
cules, given that group 3 Omps are highly abundant and they
strongly associate with the LPS (19, 22, 36). A search of the B.
abortus genome reveals more than 25 proteins and lipoproteins
predicted to be located in the OM, a fact that is sustained by a
recent proteomic analysis of B. abortus OM fragments (26).
Therefore, it is possible that some of these proteins are also
affected, as we have seen in 2D gels of OM fragments from
these mutants (data not shown).
We observed that RAW 264.7 murine macrophages infected
with the B. abortus omp3a mutant generated slightly larger
amounts of TNF- than the WT strain. These results are in
agreement with those previously reported (5, 12, 20), showing
that the production of TNF- in murine macrophages is not
related to Omp3a. However, the bvrS mutant, harboring very
low quantities of Omp3a, Omp3b, and most likely other mem-
brane defects (28), induced small amounts of TNF-. This
effect is probably due to phenotypic changes in the cell enve-
lope influencing the biological behavior of the mutant strains.
Consistent with the lack of important OM defects, the
omp3a and omp3b mutants and the WT strain displayed almost
identical replication rates in cells and similar numbers of col-
onies in mouse spleens. This is in sharp contrast with the fast
clearing of the bvrS mutant. The omp3a and omp3b mutants
bind to more cells and are internalized more by the cell pop-
ulation, and in absolute numbers, they show higher counts of
total and internalized bacteria per cell than the WT strain.
Therefore, and contrary to what is observed with the bvrS
mutant, the internalization process in these bacteria is not
impaired. This observation suggests that the two-component
system is affecting the internalization process in a way not
directly related to the presence of Omp3a or Omp3b. Although
the omp3a and omp3b mutants are more efficiently internalized
than the WT, they show replication and survival rates in cells
and mice similar to those shown by the WT. The reason for this
remains elusive. One possibility is that, in spite of their higher
internalization rates, the actual absolute number of mutant
bacteria reaching the final niche, i.e., the endoplasmic reticu-
lum, is the same as the absolute number of WT bacteria.
Overall, these results indicate that the absence of one of these
two group 3 Omps does not generate attenuated B. abortus
phenotypes. In previous reports, it has been described that a B.
abortus 2308 omp3a deletion mutant opsonized with hyperim-
mune murine serum has delayed growth in late gestational
bovine chorionic trophoblasts and cultured bovine macro-
phages. In fact, the percent survival of this mutant does not
reach the levels of the WT after 48 h of infection (14). How-
ever, the data were normalized so that 100% survival repre-
sented the number of bacteria recovered after a 2-h incubation
with macrophages. Our data show that both the omp3a and
omp3b mutants were more efficiently internalized than the
WT, and therefore their initial CFU counts were higher than
those obtained for the WT. This difference is more obvious for
HeLa cells than for murine macrophages. Conversely, during
FIG. 6. Infection of the spleens of BALB/c mice with different B.
abortus strains. Mice were infected intraperitoneally with 105 CFU/
mouse, except for the bvrS mutant, for which the dose was 108 CFU/
mouse. Values are means standard deviations (n 5). The detection
limit was 0.6 log CFU/spleen (3 to 4 CFU/spleen).
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the following hours after infection but before replication oc-
curs, the CFU counts decreased to the WT level. This shows
that these mutants have an initially higher destruction rate
than the WT strain, as suggested by Edmonds et al. (14).
However, the CFU counts after 12 h of infection show that
both mutants reached the same absolute numbers as the WT,
indicating that the numbers of bacteria that replicate and con-
sequently adapt to the intracellular niche are the same. Indeed,
if our results are represented in the same way as they were by
Edmonds et al. (14), the data are the same. Therefore, it is
clear that increased efficiency of internalization compensates
for augmented intracellular destruction.
Caro-Herna´ndez et al. (4) showed that a B. ovis omp3b
mutant is attenuated in a mouse model compared with the
parent strain. However, and in contrast to what we observed
with our B. abortus omp3b mutant, the B. ovis omp3b mutant
has greater susceptibility to nonimmune serum and has growth
defects, particularly when reaching the stationary phase. These
differences might be explained from the OM physiology con-
text; because B. ovis is a rough bacterium, it is more likely that
the absence of Omp3b might result in drastic modifications of
its biology. On the other hand, and consistent with our results,
Caro-Herna´ndez et al. also showed that a B. ovis omp3a mu-
tant is virulent in the same mouse model (4). Conversely,
Edmonds et al. (14, 15) reported that a B. abortus omp3a
mutant was attenuated in cattle and in mice 18 to 20 weeks
postinfection. In our mouse experiments, we did not detect
significant variations in a 24-week follow-up period with
respect to the WT. At the present time, we do not have an
explanation for this discrepancy. However, there is more evi-
dence consistent with our observations. Neither the kinetics of
spleen infections nor the residual virulence of B. melitensis
Rev1 in mice is modified by deletion of group 3 Omp31 (8).
Although further research is needed, a hypothesis is that group
3 Omps are an interdependent and coordinated group of pro-
teins that have become redundant to secure the presence of at
least one member in the OM and to permit certain cell enve-
lope plasticity in order to live in different environments. This
would account for the role of BvrR/BvrS and for the somewhat
surprising phenotype of the omp3a and omp3b mutants since,
according to the hypothesis, the absence of one protein of the
group will be balanced by one or more of the other members.
In fact, it has been observed that knocking out omp25c,
omp25d, or omp3b increases Omp25b production in B. suis,
and on this basis, a compensatory regulation within group 3
Omps is suggested (37). Furthermore, a tight balance of the
group 3 Omps seems to be essential for the integrity of the B.
ovis membrane (4). Virulent WT B. abortus naturally lacks
functional genes for group 3 Omp31 and Omp25b (23), show-
ing that the absence of one or two members of this family is not
decisive for virulence. All this indirect evidence has to be
considered with caution because B. melitensis and B. abortus do
not have the same profile of group 3 Omps and there are
contradictory reports on the level of group 3 Omps in B. suis
mutants with mutations in bvrR and/or bvrS (3, 37). Neverthe-
less, the compensatory hypothesis would explain why muta-
tions in a single Omp do not cause marked phenotypic
changes, while dysfunction in BvrR/BvrS has a profound influ-
ence, at least in B. abortus. In this regard, it can also be
hypothesized that the BvrR/BvrS influence may extend directly
or indirectly to other group 3 members, to other OM mole-
cules, or beyond the OM structure. A proteomic analysis of the
complete cell envelope of the B. abortus WT and avirulent bvrS
and bvrR mutants indicates that this might be the case, since
these mutants have small amounts of different group 3 Omps
and altered quantities of other Omps and periplasmic compo-
nents compared with the WT (26).
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